Accelerating Innovation at Leica Biosystems slide image

Accelerating Innovation at Leica Biosystems

Core Sales Growth and Core Sales Growth Including Cytiva Total sales growth (GAAP) Impact of: Acquisitions/divestitures DANAHER CORPORATION % Change Six- Month Period Ended July 2, 2021 vs. Comparable 2020 Period 46.0 % % Change Year Ended December 31, 2020 vs. Comparable 2019 Period 24.5 % % Change Year Ended December 31, 2019 vs. Comparable 2018 Period 5.0 % % Change Year Ended December 31, 2018 vs. Comparable 2017 Period 8.5 % % Change Year Ended December 31, 2017 vs. Comparable 2016 Period 8.5 % % Change Year Ended December 31, 2016 vs. Comparable 2015 Period 17.0 % (16.0) (18.0) (1.0) (2.0) (4.5) Currency exchange rates (3.5) 2.0 (0.5) (0.5) (15.0) 1.0 Core sales growth (non-GAAP) 26.5 % 6.5 % 6.0 % 6.0 % 3.5 % 3.0 % Impact of Cytiva sales growth (net of divested product lines) Core sales growth including Cytiva (non-GAAP) 4.5 31.0 % 3.0 9.5 % Note: Danaher calculates period-to-period core sales growth including Cytiva by adding Cytiva sales to core sales for both the baseline and current periods. Beginning in the second quarter of 2021, Cytiva sales are included in core sales, and therefore we no longer provide the measure "core sales including Cytiva” for quarterly periods beginning with the second quarter of 2021. All prior periods presented in the table above are the as reported figures from the periods presented prior to the separation of Envista Holdings Corporation ("Envista") (which Danaher divested in 2019). The 2016, 2017 and 2018 metrics include Envista. Total sales growth (GAAP) Impact of: Acquisitions/divestitures Currency exchange rates Core sales growth (non-GAAP) % Change Year Ended December 31, 2015 vs. Comparable 2014 Period Total Company Life Sciences Segment 32.0% 7.5 % (10.5) 6.0 (35.5) 6.5 3.0 % 3.0 % Note: All Total Company metrics presented in the table above are the as reported figures from the period presented prior to the separation of Fortive Corporation ("Fortive") (which Danaher divested in 2016) and Envista and include both Fortive and Envista. The Life Sciences Segment metrics reflect the recast figures when the segment was created in 2016. 1
View entire presentation